[The antidepressant viloxazin. A multicenter study under practice conditions].

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Medicine

Background:

• Depression is a common psychiatric condition with various subtypes, including endogenous and reactive depression.
• Viloxazine is an antidepressant medication used for treating depressive symptoms.
• Treatment efficacy can vary depending on the specific symptoms and whether combination therapy is used.

Purpose of the Study:

• To evaluate the efficacy of viloxazine in treating patients with depressive symptoms.
• To compare the effectiveness of viloxazine monotherapy versus combination therapy with tranquilizers.

Main Methods:

• An open, multicenter study involving 212 patients with depressive symptoms.
• Patients received viloxazine for one month, either alone or in combination with minor or major tranquilizers.
• Symptom improvement was assessed to determine treatment outcomes.

Main Results:

• Overall improvement in depressive symptoms was observed in 77% of patients.
• Specific symptoms like depressive mood, anxiety, and reduced activity showed significant improvement.
• Combination therapy demonstrated superior efficacy in managing sleep disturbances, psychomotor agitation, and internal restlessness compared to viloxazine monotherapy.

Conclusions:

• Viloxazine is an effective treatment for a majority of patients with depressive symptoms.
• Combination therapy may be beneficial for specific symptom clusters, particularly those involving agitation and sleep disturbances.
• Further research could explore optimal combination strategies for different depression subtypes.